Hepatitis Monthly

Published by: Kowsar

Prevalence of Hepatitis C Among Australian Aboriginal and Torres Strait Islander people: A Systematic Review and Meta-Analysis

Simon Graham 1 , * , Mary-Ellen Harrod 2 , Jenny Iversen 3 and Jane Simone Hocking 1
Authors Information
1 Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia
2 New South Wales Users and AIDS Association, Sydney, New South Wales, Australia
3 Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia
Article information
  • Hepatitis Monthly: July 2016, 16 (7); e38640
  • Published Online: July 2, 2016
  • Article Type: Review Article
  • Received: April 21, 2016
  • Revised: May 14, 2016
  • Accepted: June 13, 2016
  • DOI: 10.5812/hepatmon.38640

To Cite: Graham S, Harrod M, Iversen J, Simone Hocking J. Prevalence of Hepatitis C Among Australian Aboriginal and Torres Strait Islander people: A Systematic Review and Meta-Analysis, Hepat Mon. 2016 ;16(7):e38640. doi: 10.5812/hepatmon.38640.

Copyright: Copyright © 2016, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
  • 1. Hepatitis c virus projections working group: Estimates and projections of the hepatitis c virus epidemic in Australia. 2006;
  • 2. MacDonald M, Crofts N, Kaldor J. Transmission of hepatitis C virus: rates, routes, and cofactors. Epidemiol Rev. 1996; 18(2): 137-48[PubMed]
  • 3. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004; 11(2): 97-107[PubMed]
  • 4. The health and welfare of Australia's Aboriginal and Torres Strait Islander peoples. 2015;
  • 5. The health of Australia's prisoners. 2012;
  • 6. Fourth National Aboriginal and Torres Strait Islander Blood-borne Viruses and Sexually Transmissible Infections Strategy, 2014-2017. 2014;
  • 7. Cunningham J, Rumbold AR, Zhang X, Condon JR. Incidence, aetiology, and outcomes of cancer in Indigenous peoples in Australia. Lancet Oncol. 2008; 9(6): 585-95
  • 8. Main findings, bloodborne viral and sexually transmitted infections in aboriginal and torres strait islander people: Surveillance and evaluation report. 2015;
  • 9. Iversen J, Maher L. Australian needle and syringe program survey. 2015;
  • 10. Iversen J, Wand H, Topp L, Kaldor J, Maher L. Reduction in HCV incidence among injection drug users attending needle and syringe programs in Australia: a linkage study. Am J Public Health. 2013; 103(8): 1436-44[DOI][PubMed]
  • 11. Nguyen O. Needle syringe programs: A return on investment. 2010; 17
  • 12. Kwon JA, Anderson J, Kerr CC, Thein HH, Zhang L, Iversen J, et al. Estimating the cost-effectiveness of needle-syringe programs in Australia. AIDS. 2012; 26(17): 2201-10[DOI][PubMed]
  • 13. Dore GJ. The changing therapeutic landscape for hepatitis C. Med J Aust. 2012; 196(10): 629-32[PubMed]
  • 14. Doctors prescribing new hepatitis C treatments from today. 2016;
  • 15. Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma Group . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009; 339[DOI][PubMed]
  • 16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414): 557-60[DOI][PubMed]
  • 17. Sanderson S, Tatt ID, Higgins JP. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol. 2007; 36(3): 666-76[DOI][PubMed]
  • 18. Boston RC, Sumner AE. STATA: a statistical analysis system for examining biomedical data. Adv Exp Med Biol. 2003; 537: 353-69[PubMed]
  • 19. Butler TG, Dolan KA, Ferson MJ, McGuinness LM, Brown PR, Robertson PW. Hepatitis B and C in New South Wales prisons: prevalence and risk factors. Med J Aust. 1997; 166(3): 127-30[PubMed]
  • 20. Butler T, Spencer J, Cui J, Vickery K, Zou J, Kaldor J. Seroprevalence of markers for hepatitis B, C and G in male and female prisoners--NSW, 1996. Aust N Z J Public Health. 1999; 23(4): 377-84[PubMed]
  • 21. Roberts C, Crofts N. Hitting up in the top end: characteristics of needle exchange clients in Darwin. Aust N Z J Public Health. 2000; 24(1): 82-5[PubMed]
  • 22. Gilles M, Swingler E, Craven C, Larson A. Prison health and public health responses at a regional prison in Western Australia. Aust N Z J Public Health. 2008; 32(6): 549-53[DOI][PubMed]
  • 23. van der Poorten D, Kenny DT, George J. Prevalence of and risk factors for hepatitis C in Aboriginal and non-Aboriginal adolescent offenders. Med J Aust. 2008; 188(10): 610-4[PubMed]
  • 24. Templeton DJ, Tyson BA, Meharg JP, Habgood KE, Bullen PM, Malek S, et al. Aboriginal health worker screening for sexually transmissible infections and blood-borne viruses in a rural Australian juvenile correctional facility. Sex Health. 2010; 7(1): 44-8[DOI][PubMed]
  • 25. Ward J, Topp L, Iversen J, Wand H, Akre S, Kaldor J, et al. Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs. Aust N Z J Public Health. 2011; 35(5): 421-6[DOI][PubMed]
  • 26. Davies J, Jabbar Z, Gagan F, Baird RW. Blood-borne viruses in the haemodialysis-dependent population attending Top End Northern Territory facilities 2000-2009. Nephrology (Carlton). 2012; 17(5): 501-7[DOI][PubMed]
  • 27. Paquette D, McEwan M, Bryant J. Risk practices among aboriginal people who inject drugs in New South Wales, Australia. AIDS Behav. 2013; 17(7): 2467-73[DOI][PubMed]
  • 28. Foy A, Tierney A. Internal medicine in the bush: a clinical audit of a rural and remote outreach programme. Intern Med J. 2014; 44(4): 369-74[PubMed]
  • 29. Luciani F, Bretana NA, Teutsch S, Amin J, Topp L, Dore GJ, et al. A prospective study of hepatitis C incidence in Australian prisoners. Addiction. 2014; 109(10): 1695-706[DOI][PubMed]
  • 30. Parker C, Tong SY, Dempsey K, Condon J, Sharma SK, Chen JW, et al. Hepatocellular carcinoma in Australia's Northern Territory: high incidence and poor outcome. Med J Aust. 2014; 201(8): 470-4[PubMed]
  • 31. Harrod ME, Dore GJ, Gregson S, Belfrage M, Delaney-Thiele D, Hammond B. A descriptive analysis of routine HCV testing data from four Aboriginal Community Controlled Health Services: testing, positivity, follow-up and context of testing. 2014;
  • 32. Saulo D, Harrod ME, Reekie J, Kaldor J, Butler T. Blood borne virus prevalence and risk behaviours in Indigenous and non-Indigenous prison entrants. 2014;
  • 33. Su JY, Broadfoot J. Sero-prevalence of hepatitis C virus antibody among prisoners in the Northern territory. 2013; 20
  • 34. Kinner SA, Jenkinson R, Gouillou M, Milloy MJ. High-risk drug-use practices among a large sample of Australian prisoners. Drug Alcohol Depend. 2012; 126(1-2): 156-60[DOI][PubMed]
  • 35. Sexual health and bloodborne viruses. 2012;
  • 36. Reekie JM, Levy MH, Richards AH, Wake CJ, Siddall DA, Beasley HM, et al. Trends in HIV, hepatitis B and hepatitis C prevalence among Australian prisoners - 2004, 2007, 2010. Med J Aust. 2014; 200(5): 277-80[PubMed]
  • 37. Butler T, Callander D, Simpson M. National prison entrants’ bloodborne virus and risk behaviour survey 2004, 2007, 2010 and 2013. 2015;
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader